Law360, New York (April 10, 2006, 12:00 AM EDT) -- Despite settling litigation over blockbuster drug Effexor in October, drug maker Wyeth is heading back to court to defend the popular antidepressant after another generic drug maker took a swipe at its patents.
Impax Laboratories was sued by Wyeth after it filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration. The suit was filed in the U.S. District Court for the District of Delaware.
Impax issued a statement calling the suit an attempt to block lower-priced medication from entering the market....
Wyeth, Impax Head To Court Over Effexor
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
